Works matching IS 00084042 AND DT 2022 AND VI 100 AND IP 9


Results: 7
    1
    2
    3
    4
    5
    6
    7

    A privileged dual action Alzheimer's disease therapeutic platform targeting immunopathic and proteopathic mechanisms: (E)-3-styrylindoles as inhibitors of indoleamine 2,3-dioxygenase-mediated tryptophan metabolism and β-amyloid aggregation.

    Published in:
    Canadian Journal of Chemistry, 2022, v. 100, n. 9, p. 660, doi. 10.1139/cjc-2021-0324
    By:
    • Kelly, Brendan J.;
    • Diez-Cecilia, Elena;
    • Pan, Luzhe;
    • Sweeting, Braden;
    • Villar, Laura;
    • Kreft, Alexander;
    • Gupta, Mayuri;
    • Johnson, Shea L.;
    • Weaver, Donald F.
    Publication type:
    Article